Argentarii’s Novartis NVS Stock Holding History

Argentarii’s Portfolio NVS Stock Details NVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-1,561	Closed	-$238K	–	221
2026 Q1	$238K	Buy	1,561 +19	+1%	+$2.91K	0.08%	180
2025 Q4	$213K	Buy	+1,542	New	+$202K	0.07%	191

Other funds holding NVS

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Argentarii's NVS Position: Q2 2026 in Review

Argentarii sold out of Novartis (NVS) in Q2 2026, closing a stake of 1,561 shares — an estimated $238K sold.

Argentarii first reported a position in NVS in Q4 2025 and held it in 2 quarters. The position peaked at $238K in Q1 2026. 1,621 funds tracked by Wall St. Rank hold NVS as of Q2 2026.

Argentarii reported no remaining Novartis position as of Q2 2026 after selling out during the quarter.
Argentarii sold 1,561 Novartis shares in Q2 2026, an estimated $238K.
Argentarii first reported a position in Novartis in Q4 2025 and held it in 2 quarters.
Argentarii's Novartis position peaked at $238K in Q1 2026.
1,621 funds tracked by Wall St. Rank held Novartis as of Q2 2026.

Based on Argentarii's 13F filing for Q2 2026, filed 12 Aug 2026.